Samsung Biologics signs deal with Enzolytics
Samsung Biologics signed a contract development and manufacturing organization (CDMO) deal with Texas-based Enzolytics for two drugs, including a Covid-19 treatment candidate, the Korean biopharmaceutical company said Thursday.